DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,908,000 | -7.2% | 144,439 | 0.0% | 0.20% | +10.6% |
| Q2 2021 | $5,288,000 | -41.0% | 144,439 | -27.8% | 0.18% | -10.0% |
| Q1 2021 | $8,968,000 | -21.4% | 200,000 | 0.0% | 0.20% | -26.5% |
| Q4 2020 | $11,414,000 | -11.0% | 200,000 | -20.0% | 0.27% | -44.8% |
| Q3 2020 | $12,825,000 | -32.7% | 250,000 | -21.6% | 0.49% | -32.2% |
| Q2 2020 | $19,046,000 | +32.2% | 318,914 | -8.9% | 0.73% | +8.5% |
| Q1 2020 | $14,410,000 | -48.6% | 350,000 | -22.2% | 0.67% | -40.1% |
| Q4 2019 | $28,008,000 | +4.7% | 450,000 | -42.9% | 1.12% | -31.4% |
| Q3 2019 | $26,762,000 | – | 788,500 | – | 1.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $18,687,872 | 15.44% |
| Redmile Group, LLC | 5,582,105 | $86,243,522 | 3.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,218,638 | $80,627,957 | 1.80% |
| BRAIDWELL LP | 3,241,351 | $50,078,873 | 1.65% |
| Parkman Healthcare Partners LLC | 491,772 | $7,597,877 | 1.65% |
| Sunesis Advisors, LLC | 96,299 | $1,487,820 | 1.07% |
| ARMISTICE CAPITAL, LLC | 4,100,000 | $63,345,000 | 0.91% |
| Deep Track Capital, LP | 1,363,201 | $21,061,455 | 0.86% |
| AlphaCentric Advisors LLC | 72,500 | $1,120,125 | 0.77% |
| Ikarian Capital, LLC | 174,510 | $2,696,179 | 0.61% |